Frequently Asked Questions

Get answers to common questions about Compounded Semaglutide.

Compounded Semaglutide is a GLP-1 receptor agonist that mimics gut hormones to slow gastric emptying, reduce hunger signals, and increase satiety. Administered weekly within a tailored plan, it supports consistent calorie reduction and sustainable weight loss under medical supervision.

Eligibility is determined during a medical evaluation considering BMI, health history, current medications, and weight-loss goals. Our clinicians screen for contraindications and design individualized plans; an initial consultation and labs are required to confirm safe treatment.

Mild gastrointestinal symptoms like nausea, diarrhea, constipation, and occasional vomiting are most common, typically easing after several weeks. Headache or low appetite can occur. Serious reactions are rare; report severe or persistent symptoms to your provider for assessment.

Our medical team establishes an individualized starting dose based on your medical history and goals, then titrates gradually to minimize side effects and optimize effectiveness. Dosing adjustments occur during scheduled follow-ups and labs to ensure safety and long-term tolerability.

Many patients notice reduced appetite and modest weight changes within the first 4–12 weeks; meaningful, steady weight loss typically becomes evident after several months. Results vary with lifestyle, adherence, and dosing; ongoing medical support helps sustain progress.

Yes — it's most effective when paired with individualized nutrition, physical activity, behavior modification, and monitoring. Our team integrates Semaglutide into a comprehensive weight-management plan, adjusting therapies as needed and providing education to maximize long-term health outcomes.